Compile Data Set for Download or QSAR
Report error Found 128 Enz. Inhib. hit(s) with all data for entry = 12387
TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699832BDBM699832(US20240335431, Example 13)
Affinity DataIC50: 4nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699829BDBM699829(US20240335431, Example 10)
Affinity DataIC50: 4nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699830BDBM699830(US20240335431, Example 11)
Affinity DataIC50: 4nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699831BDBM699831(US20240335431, Example 12)
Affinity DataIC50: 6nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699858BDBM699858(US20240335431, Example 39)
Affinity DataIC50: 7nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699842BDBM699842(US20240335431, Example 23)
Affinity DataIC50: 7nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699861BDBM699861(US20240335431, Example 42)
Affinity DataIC50: 9nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699856BDBM699856(US20240335431, Example 37)
Affinity DataIC50: 9nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699885BDBM699885(2-(3-(1-((1S,2S,5R)-3-Azabicyclo[3.1.0]-hexane-2-c...)
Affinity DataIC50: 9nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699860BDBM699860(US20240335431, Example 41)
Affinity DataIC50: 10nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699850BDBM699850(US20240335431, Example 31)
Affinity DataIC50: 10nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699857BDBM699857(US20240335431, Example 38)
Affinity DataIC50: 13nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699868BDBM699868(2-(3-(1-((1S,2S,5R)-3-Azabicyclo[3.1.0-]hexane-2-c...)
Affinity DataIC50: 13nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699881BDBM699881(US20240335431, Example 53-3)
Affinity DataIC50: 14nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699883BDBM699883(US20240335431, Example 54)
Affinity DataIC50: 15nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699866BDBM699866(US20240335431, Example 47)
Affinity DataIC50: 15nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699875BDBM699875(US20240335431, Example 52-1)
Affinity DataIC50: 16nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699840BDBM699840(US20240335431, Example 21)
Affinity DataIC50: 16nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699838BDBM699838(US20240335431, Example 19 | BDBM699847)
Affinity DataIC50: 16nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699838BDBM699838(US20240335431, Example 19 | BDBM699847)
Affinity DataIC50: 17nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699849BDBM699849(US20240335431, Example 30)
Affinity DataIC50: 17nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699834BDBM699834(US20240335431, Example 15)
Affinity DataIC50: 17nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699859BDBM699859(US20240335431, Example 40)
Affinity DataIC50: 18nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699876BDBM699876(US20240335431, Example 52-2)
Affinity DataIC50: 18nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699824BDBM699824(US20240335431, Example 5)
Affinity DataIC50: 18nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699843BDBM699843(US20240335431, Example 24)
Affinity DataIC50: 19nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699839BDBM699839(US20240335431, Example 20 | BDBM699848)
Affinity DataIC50: 20nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699862BDBM699862(US20240335431, Example 43)
Affinity DataIC50: 20nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699835BDBM699835(US20240335431, Example 16)
Affinity DataIC50: 21nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699836BDBM699836(US20240335431, Example 17)
Affinity DataIC50: 21nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699874BDBM699874(2-(3-(1-((1S,2S,5R)-3-Azabicyclo[3.1.0]hexane-2-ca...)
Affinity DataIC50: 22nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699839BDBM699839(US20240335431, Example 20 | BDBM699848)
Affinity DataIC50: 22nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699826BDBM699826(US20240335431, Example 7)
Affinity DataIC50: 24nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699855BDBM699855(US20240335431, Example 36)
Affinity DataIC50: 24nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699846BDBM699846(US20240335431, Example 27)
Affinity DataIC50: 25nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699841BDBM699841(US20240335431, Example 22)
Affinity DataIC50: 25nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699822BDBM699822(US20240335431, Example 3)
Affinity DataIC50: 25nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699827BDBM699827(US20240335431, Example 8)
Affinity DataIC50: 27nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699844BDBM699844(US20240335431, Example 25)
Affinity DataIC50: 27nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699872BDBM699872((S)-2-(3-(1-(5,5-Dimethylpyrrolidine-2-carbonyl)pi...)
Affinity DataIC50: 29nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699853BDBM699853(US20240335431, Example 34)
Affinity DataIC50: 29nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699870BDBM699870((S)-2-(3-(1-(4-Azaspiro[2.4]heptane-5-carbonyl)pip...)
Affinity DataIC50: 29nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699793BDBM699793(US20240335431, Example 1)
Affinity DataIC50: 29nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699891BDBM699891((1-((S)-4-Azaspiro[2.4]heptane-5-carbonyl)piperidi...)
Affinity DataIC50: 30nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699888BDBM699888(2-(3-(1-((1S,2S,5R)-3-Azabicyclo[3.1.0-]hexane-2-c...)
Affinity DataIC50: 33nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699865BDBM699865(US20240335431, Example 46)
Affinity DataIC50: 34nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699864BDBM699864(US20240335431, Example 45)
Affinity DataIC50: 36nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699851BDBM699851(US20240335431, Example 32)
Affinity DataIC50: 36nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699837BDBM699837(US20240335431, Example 18)
Affinity DataIC50: 37nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 699852BDBM699852(US20240335431, Example 33)
Affinity DataIC50: 37nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

Displayed 1 to 50 (of 128 total ) | Next | Last >>
Jump to: